In Vivo UVA Sunscreen Tests "Clinically Irrelevant...Unethical" - Diffey
This article was originally published in The Tan Sheet
Executive Summary
The use of in vivo methods for UVA sunscreen testing is "clinically irrelevant" and "unethical," Brian Diffey, PhD, Newcastle General Hospital, maintained at the American Association of Dermatology UVA consensus conference in Washington, D.C. Feb. 4.
You may also be interested in...
UVA Protection Provided By 10% Of Sunscreens Tested - Researcher Diffey
Only six of 59 commercially available sunscreens met the critical wavelength standard of +/-370 nm to establish efficacy against UVA light, Brian Diffey, Newcastle General Hospital, England, et al., determine in a study published in the December Journal of the American Academy of Dermatology.
UVA Protection Provided By 10% Of Sunscreens Tested - Researcher Diffey
Only six of 59 commercially available sunscreens met the critical wavelength standard of +/-370 nm to establish efficacy against UVA light, Brian Diffey, Newcastle General Hospital, England, et al., determine in a study published in the December Journal of the American Academy of Dermatology.
UVA Protection Provided By 10% Of Sunscreens Tested - Researcher Diffey
Only six of 59 commercially available sunscreens met the critical wavelength standard of +/-370 nm to establish efficacy against UVA light, Brian Diffey, Newcastle General Hospital, England, et al., determine in a study published in the December Journal of the American Academy of Dermatology.